Chengdu Kanghua Biological Products (300841) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.026x

Based on the latest financial reports, Chengdu Kanghua Biological Products (300841) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥92.89 Million ≈ $13.59 Million USD) by net assets (CN¥3.51 Billion ≈ $513.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300841 company net worth for the company's overall valuation and market capitalisation.

Chengdu Kanghua Biological Products - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Chengdu Kanghua Biological Products's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Chengdu Kanghua Biological Products Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chengdu Kanghua Biological Products ranked by their cash flow conversion efficiency. Explore Chengdu Kanghua Biological Products cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Guangdong Silvere Sci and Tech SHE:300221	0.048x
Jolywood Suzhou Sunwatt Co Ltd SHE:300393	-0.071x
Shenzhen Sunshine Laser & Electronics Technology Co Ltd SHE:300227	-0.059x
Smarter Microelectronics (Guangzhou) Co. Ltd. A SHG:688512	N/A
Amphastar P NASDAQ:AMPH	0.067x
Amerant Bancorp Inc. NYSE:AMTB	0.024x
Ficont Industry (Beijing) Co. Ltd. SHG:605305	0.028x
Shunfa Hengye Corp SHE:000631	0.000x

Annual Cash Flow Conversion Efficiency for Chengdu Kanghua Biological Products (2015–2024)

The table below shows the annual cash flow conversion efficiency of Chengdu Kanghua Biological Products from 2015 to 2024. View 300841 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.45 Billion ≈ $504.48 Million	CN¥572.24 Million ≈ $83.74 Million	0.166x	+1.62%
2023-12-31	CN¥3.51 Billion ≈ $514.22 Million	CN¥573.98 Million ≈ $83.99 Million	0.163x	+157.64%
2022-12-31	CN¥3.08 Billion ≈ $450.07 Million	CN¥194.99 Million ≈ $28.53 Million	0.063x	+29.90%
2021-12-31	CN¥2.67 Billion ≈ $390.75 Million	CN¥130.33 Million ≈ $19.07 Million	0.049x	-73.93%
2020-12-31	CN¥1.97 Billion ≈ $288.92 Million	CN¥369.56 Million ≈ $54.08 Million	0.187x	-41.14%
2019-12-31	CN¥574.65 Million ≈ $84.09 Million	CN¥182.73 Million ≈ $26.74 Million	0.318x	+103.86%
2018-12-31	CN¥367.70 Million ≈ $53.81 Million	CN¥57.35 Million ≈ $8.39 Million	0.156x	-67.34%
2017-12-31	CN¥188.37 Million ≈ $27.56 Million	CN¥89.96 Million ≈ $13.16 Million	0.478x	+1838.25%
2016-12-31	CN¥-96.21 Million ≈ $-14.08 Million	CN¥2.64 Million ≈ $386.80K	-0.027x	+56.55%
2015-12-31	CN¥-102.87 Million ≈ $-15.05 Million	CN¥6.51 Million ≈ $951.92K	-0.063x	--

About Chengdu Kanghua Biological Products

SHE:300841 China Biotechnology

Market Cap

$980.24 Million

CN¥6.70 Billion CNY

Market Cap Rank

#9049 Global

#2232 in China

Share Price

CN¥51.55

Change (1 day)

+2.59%

52-Week Range

CN¥42.86 - CN¥84.21

All Time High

CN¥399.08